Larka

Newsletters

Every week, discover in a precise and easy way how your business has been impacted by the recent developments in the pharma & biotech industry. Subscribe!

 

The News You Need On Pharma & Contract Manufacturing

Every week, our team of analysts and writers is proud to provide more than 4,500 subscribers with up-to-date news, covering Corporate, CDMOs, R&D, and regulatory news.

 
flower.jpg

New merger in the early-phase CDMO industry.

18th of September, 2017


canada_mod.jpg

Canadian spin off, Chinese acquirer.

11th of September, 2017

rails_mod.jpg

India's still in US FDA's sights.

4th of September, 2017

fast_mod.jpg

Bio CDMO landscape is moving fast.

28th of August, 2017

bio_fluids_mod.jpg

New merger in the bio-manufacturing industry.

21st of August, 2017

shape_mod.jpg

API market still reshapes

14th of August, 2017

New player enters the game.

7th of August, 2017

No summer break for supply contracts.

31st of July, 2017

Opiates production industry still on the move.

24th of July, 2017

Amatsi acquired by Eurofins Labs.

17th of July, 2017

New quality issues for Asian API

10th of July, 2017

New option for oligonucleotide manufacturing.

3rd of July, 2017

climber_mod.jpg

Big Pharma keeps shifting towards biologics.

26th of June, 2017

Dr. Reddy's: 1 down, 4 to go.

19th of June, 2017

Roquette sets foot in Brazil.

12th of June, 2017

CDMOs close dev agreements.

5th of June, 2017

US gets FDA clearance, China gets a warning.

29th of May, 2017